Global Health Ventures, a healthcare technology merchant bank, has signed a licensing agreement with Globe Laboratories, a privately-held biotechnology company in Vancouver, Canada.
Subscribe to our email newsletter
Under the terms of the agreement, Globe Laboratories will license a new drug formulation for male sexual enhancement. The drug, which is in Phase I/II clinical trials, is expected to have a significant market once all trial studies and regulatory filings are completed.
The entire financing for the project will be committed by Global Health Ventures, while Globe Laboratories will benefit from marketing of the product through royalties, milestones, and research contracts agreed to by the two companies.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.